drugset / Trial / NCT03450499
Analgesia Effects of Intravenous Ketamine After Spinal Anesthesia for Non-elective Cesarean Section
RandomizedParallel-groupDouble-blindTreatment
Summary
This randomized double blind study will be conducted in pregnant woman planned for non elective cesarean section under spinal anesthesia. Ketamine group will receive intravenous 0.25 mg/kg and placebo group will receive same amount of normal saline after spinal anesthesia prior to skin incision. Postoperative outcomes measures are total opioid consumption and pain scores for 24 hrs.
Timeline
- Start
- 2018-04-01
- Primary completion
- 2019-03-07
- Completion
- 2019-03-07
Outcome
Met primary endpoint
paper 0 (0-4.67) mg in ketamine group and 1 (0-6) mg in saline group (p=0.003). PMID 34193480 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ketamine | Small molecule | 0.25 mg/kg | Intravenous |
Indications
No indication recorded.